Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

2.27
Delayed Data
As of 4:00pm ET
 -0.02 / -0.87%
Today’s Change
1.55
Today|||52-Week Range
4.20
-14.34%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close2.29
Today’s open2.30
Day’s range2.20 - 2.30
Volume810,695
Average volume (3 months)835,386
Market cap$152.9M
Dividend yield--
Data as of 4:00pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)-76.36%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,602.80
Price/Book3.45

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc+0.06+2.55%
EVGNEvogene Ltd+0.05+0.82%
AXSMAxsome Therapeutics ...-0.05-0.66%
CBMGCellular Biomedicine...-0.73-6.07%
Data as of 4:02pm ET, 06/29/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$100.0K
Annual profit (last year)-$58.6M
Net profit margin-58,587.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Financial Officer &
Treasurer
John Y. Caloz
Corporate headquarters
Los Angeles, California

Forecasts

Partner Offers

Search for Jobs